Achillion Pharmaceuticals Assigned Patent for Substituted Aliphanes
Copyright © Targeted News Service, 2017
2017-12-09
Copyright © Targeted News Service, 2017
2017-12-09
ALEXANDRIA, Va., Dec. 9 -- Achillion Pharmaceuticals, New Haven, Connecticut, has been assigned a patent (9,833,440) developed by nine co-inventors for "substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections." The co-inventors are Jason Allan Wiles, Hamden, Connecticut, Qiuping Wang, Bethany, Connecticut, Akihiro Hashimoto, Branford, Connecticut, Godwin Pais, Hamden, Connecticut, Xiangzhu Wang, Madison, Connecticut, . . .